ロード中...
Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
BACKGROUND: Therapeutic idiotypic (Id) vaccination is an experimental treatment for selected B cell malignancies. A broader use of Id-based vaccination, however, is hampered by the complexity and costs due to the individualized production of protein vaccines. These limitations may be overcome by tar...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4119056/ https://ncbi.nlm.nih.gov/pubmed/25059102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-207 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|